Study to evaluate seladelpar in patients with primary biliary cholangitis (H-49180)
Description
Content
Cymabay: cb8025-31731-re: assure: An open label long-term study to evaluate the safety and tolerability of seladelpar in subjects with primary biliary cholangitis (pbc).
Contact
Phone 1: 713–798–1037
IRB: H-49180
Status:
Active
Created:
